Profile data is unavailable for this security.
About the company
Vabun SA is a Poland-based company engaged in the personal products industry. The Company produces and sells cosmetics and fragrances for male and female. Vabun SA's products portfolio encompasses perfumes, such as Vabun Classic, Vabun Silver, Vabun Gold and Vabun Sport, as well as shower gels, soaps and other cosmetics for women.
- Revenue in PLN (TTM)3.95m
- Net income in PLN-47.03m
- Incorporated2015
- Employees31.00
- LocationCosma SAUl. Woloska 22AKRAKOW 02-675PolandPOL
- Phone+48 126540519
- Fax+48 126540519
- Websitehttps://cosma.pl/
More ▼
Mergers & acquisitions
| Acquired company | COS:WSE since announced | Transaction value |
|---|---|---|
| Undisclosed Pharmaceuticals Distributor | -7.35% | -- |
Data delayed at least 15 minutes, as of Nov 15 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lasa Supergenerics Ltd | 50.76m | -9.47m | 62.59m | 77.00 | -- | -- | -- | 1.23 | -3.92 | -3.92 | 20.94 | -- | -- | -- | -- | 13,586,300.00 | -- | -3.86 | -- | -5.34 | 26.41 | 32.53 | -18.65 | -5.30 | -- | -4.49 | -- | -- | -19.47 | -9.26 | 43.73 | -- | -- | -- |
| Gelteq Ltd | 0.00 | -6.26m | 63.79m | -- | -- | 1.11 | -- | -- | -0.1599 | -0.1599 | 0.00 | 1.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 154.78m | -42.50m | 65.43m | 91.00 | -- | 0.6093 | -- | 0.4227 | -0.7328 | -0.7328 | 2.67 | 1.87 | 0.4501 | 0.8643 | 3.17 | 415,225.80 | -12.35 | -7.03 | -17.75 | -9.52 | 82.58 | 79.95 | -27.45 | -17.64 | 1.26 | -38.85 | 0.382 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Cosma SA | 3.95m | -47.03m | 66.09m | 31.00 | -- | 1.94 | -- | 16.72 | -0.4301 | -0.4301 | 0.0362 | 0.2343 | 0.0733 | 0.8409 | 3.05 | 136,278.60 | -87.24 | -- | -91.46 | -- | 58.45 | -- | -1,189.90 | -- | 0.5634 | -129.62 | 0.0119 | -- | -- | -- | -18,399.08 | -- | -- | -- |
| TherapeuticsMD Inc | 6.54m | -16.25m | 66.14m | 1.00 | -- | 0.5959 | -- | 10.12 | -0.3499 | -0.291 | 0.1399 | 2.35 | 0.0355 | -- | 0.4944 | 1,596,000.00 | -8.81 | -53.35 | -11.41 | -111.61 | 31.45 | 86.67 | -248.56 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Labiana Health SA | 281.07m | -5.09m | 66.73m | 363.00 | -- | 3.22 | 4.45 | 0.2374 | -0.1692 | -0.1692 | 9.27 | 0.6652 | 1.20 | 2.06 | 6.59 | 152,437.70 | -2.20 | -4.49 | -4.52 | -7.80 | 61.64 | 59.40 | -1.83 | -4.92 | 0.8015 | 0.9877 | 0.7459 | -- | 1.06 | 6.45 | 50.54 | -- | -9.47 | -- |
| Sotac Pharmaceuticals Ltd | 50.84m | 2.01m | 67.23m | 89.00 | 33.38 | 2.94 | 18.85 | 1.32 | 3.76 | 3.76 | 94.83 | 42.67 | 0.9762 | 4.92 | 3.77 | -- | 3.87 | -- | 7.26 | -- | 21.45 | -- | 3.96 | -- | 0.8132 | 2.77 | 0.3546 | -- | 79.07 | -- | -20.38 | -- | -- | -- |
| NicOx SA | -431.81bn | -431.81bn | 67.69m | 5.00 | -- | 0.7171 | -- | -- | -- | -- | -- | 0.3166 | -- | -- | -- | -- | -- | -22.59 | -- | -24.55 | -- | -- | -- | -337.85 | -- | -- | 0.5424 | -- | 26.59 | 11.38 | 33.26 | -- | -- | -- |
| Marinus Pharmaceuticals Inc | 128.89m | -575.49m | 68.10m | 165.00 | -- | -- | -- | 0.5283 | -2.47 | -2.47 | 0.5524 | -1.21 | 0.238 | 0.6542 | 7.75 | 190,703.00 | -106.26 | -49.64 | -140.93 | -57.76 | 90.17 | -- | -446.49 | -518.96 | 1.47 | -10.06 | -- | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| Marinomed Biotech AG | 28.51m | -29.64m | 69.52m | 47.00 | -- | -- | -- | 2.44 | -4.46 | -4.46 | 4.28 | -7.69 | -- | -- | -- | 140,468.10 | -- | -33.46 | -- | -48.73 | 10.56 | 7.67 | -103.99 | -69.70 | 1.46 | -4.51 | 2.20 | -- | -18.56 | 14.50 | -6.21 | -- | -10.92 | -- |
| Cara Therapeutics Inc | 35.58m | -391.30m | 69.89m | 55.00 | -- | 24.13 | -- | 1.96 | -1.75 | -1.75 | 0.1589 | 0.0129 | 0.1042 | 0.6312 | 4.59 | 157,927.30 | -114.63 | -35.76 | -142.84 | -40.82 | 56.44 | -- | -1,099.76 | -162.10 | 4.71 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
Data as of Nov 15 2024. Currency figures normalised to Cosma SA's reporting currency: Polish New Zloty PLN
